PT2385
Description: PT2385 is a small-molecule antagonist of hypoxia-inducible factor 2 alpha studied as a targeted treatment for cancer and other hypoxia-related conditions.
Primary topic: Cancer, Hypoxia, and Metabolism (35%)
OpenAlex ID: keywords/pt2385
